CREBBP and neoplasm: In cases of chemotherapy-resistant EOC with overactivated CBP/β-catenin signaling pathway, PRI-724 has been found to enhance sensitivity of tumor to platinum chemotherapy while exhibiting significant toxicity in preclinical investigations [336, 337].